It is suitable for adult patients with advanced solid tumors with unresectable or metastatic microsatellite high instability (MSI-H) or mismatch repair gene deficiency (dMMR)
Advanced colorectal cancer patients with disease progression after previous treatment with fluorouracil, oxaliplatin and irinotecan;
Other advanced solid tumor patients with disease progression after previous treatment and no satisfactory alternative treatment options.
Let us work together to protect precious health